Moderna
MRNA
#1328
Rank
โ‚น1.182 T
Marketcap
โ‚น3,072
Share price
5.34%
Change (1 day)
-57.72%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: โ‚น1.182 Trillion

As of February 2025 Moderna has a market cap of โ‚น1.182 Trillion. This makes Moderna the world's 1328th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น1.182 T-10.78%
2024โ‚น1.324 T-58.03%
2023โ‚น3.156 T-44.72%
2022โ‚น5.710 T-25.5%
2021โ‚น7.664 T153.51%
2020โ‚น3.023 T544.07%
2019โ‚น469.41 B33.71%
2018โ‚น351.06 B

End of Day market cap according to different sources

On Feb 21st, 2025 the market cap of Moderna was reported to be:

โ‚น1.182 Trillion
by Nasdaq info icon info icon
โ‚น1.182 Trillion
by CompaniesMarketCap info icon info icon
โ‚น1.182 Trillion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น7.41 B-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น19.572 T 1,555.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น72.03 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.804 T 137.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น18.671 T 1,479.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น216.93 B-81.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น33.781 T 2,757.96%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น257.42 B-78.22%๐Ÿ‡บ๐Ÿ‡ธ USA